Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis.
18 May 2020
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
08 May 2020
“New Zealand healthcare professionals who say they don’t know enough about medicinal cannabis now have the best opportunity to change that,” says Dr Zahra Champion, Executive Director of BioTechNZ and MedCan Summit 2020 organiser.
02 March 2020
BiotechNZ is surveying NZ biotechnology companies and supporting organisations to find out the state and future opportunities for biotechnology to contribute to New Zealand’s economic growth.
20 February 2020
The medicinal cannabis industry will significantly boost the New Zealand economy, BiotechNZ executive director Dr Zahra Champion says.
11 November 2019
‘The Godfather of Cannabis’, Professor Raphael Mechoulam, will play a key role in New Zealand’s first international medicinal cannabis summit, MedCan 2020.
05 November 2019
NZ biotech companies and organisations are exploring cutting-edge research to help treat people, but that will soon be swiftly replicated for dogs, cats and other pets.
07 October 2019
Biotechnology may be one of the answers to help slow the serious and urgent issue of climate change, BiotechNZ executive director Dr Zahra Champion says.
26 September 2019
New Zealand researchers have the chance to work in France thanks to the Dumont d’Urville, a programme that aims to foster new partnerships and developing science and technology exchanges between research laboratories of excellence. The grant will pay for up to $80,000 in total per project for up to two years for travel, research expenses …
Continue reading "Applications open for Dumont d’Urville" 
